CompletedNot Applicable

Osteopathic Manipulative Medicine to Reduce Developmental Delays

United States150 participantsStarted 2021-01-05

Plain-language summary

This randomized clinical trial seeks to determine if osteopathic manipulative medicine (OMM) increases the likelihood of improved neurodevelopmental outcomes as estimated by the Test of Infant Motor Performance (TIMP).

Who can participate

Age range1 Day – 14 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 23 0/7- 33 6/7 weeks' gestational age (GA) at birth, ≥28 0/7 weeks' GA at time of consent * stable enough to tolerate gentle manipulation Exclusion Criteria: * \> 33 6/7 weeks' GA at birth * known congenital and genetic abnormalities affecting neurodevelopment * known conditions requiring surgical intervention * severe intracranial hemorrhage or other severe neurologic complications * parents unable to read and understand English

What they're measuring

Test of Infant Motor Performance (TIMP)

Timeframe: At approximately 36 weeks' corrected gestational age

Trial details

NCT IDNCT04652063

SponsorUniversity of Rochester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-01

View on ClinicalTrials.gov More Extreme Prematurity trials